Robin von Kanitz

Robin von Kanitz currently serves as Vice President and Global Product Team Lead for Cardiovascular and Heart Failure at Bayer, focusing on strategy and commercialization to ensure successful product launches and lifecycle growth. Previously, Robin held the role of Vice President and Head of Global Brand Management for Heart Failure at Bayer, overseeing the strategic launch of Verquvo®. Prior experience includes positions at Novartis, where responsibilities included leading marketing efforts for Gilenya in the U.S. and directing global launch strategies for key products such as Entresto® and Cosentyx. Robin began a career in finance as a Financial Advisor at Scope Ratings before transitioning into brand management and marketing roles in the pharmaceutical industry. Educational credentials include a Master of Science degree in Business/Managerial Economics from the University of Westminster.